Advertisement

Metabolic Brain Disease

, Volume 32, Issue 2, pp 401–413 | Cite as

Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice

  • Vishnu N. Thakare
  • Valmik D. Dhakane
  • Bhoomika M. PatelEmail author
Original Article

Abstract

Protocatechuic acid ethyl ester (PCA), a phenolic compound, exhibits neuroprotective effects through improving endogenous antioxidant enzymatic and nonezymatic system. Based on the role of oxidative stress in modulating depressive disorders and the relationship between neuroprotective and antioxidant potential of PCA, we studied if its antidepressant like effect is associated by modulation of cerebral cortex and hippocampal antioxidant alterations. Acute restraint stress (ARS) is known to induce depressive like behavior by neuronal oxidative damage in mice. Swiss albino mice subjected to ARS exhibited an increased immobility time in forced swim test, elevated serum corticosterone and produced oxidative stress dependent alterations in cerebral cortex and hippocampus mainly increased thiobarbituric acid reactive substances and reduced catalase (CAT), superoxide dismutase (SOD) activity. Treatment with PCA was able to prevent stress induced immobility time in forced swim test without altering locomotor activity in mice. Further, PCA treatment attenuated the elevation of serum corticosterone, lipid peroxidation and restored enzymatic antioxidants in cerebral cortex and hippocampus in ARS mice. Altogether, the experimental findings demonstrate the notion that PCA exhibit antidepressant like activity might be related, at least in part, to its capability of modulating antioxidant defense system and oxidative damage induced by ARS in cerebral cortex and hippocampus in mice and thus maintain the pro−/anti-oxidative homeostasis.

Keywords

Acute restraint stress Serum corticosterone Depressive like-behavior Hippocampal antioxidants Protocatechuic acid ethyl ester 

Notes

Acknowledgments

Authors are grateful to Prof. M. N. Navale, Founder President, Sinhgad Technical Education Society, Dr. R. N. Kane, Principal, and Rajesh R Patil, Sinhgad Institute of Pharmaceutical Sciences for providing necessary facilities, encouragement and support in the completion of present research studies.

Compliance with ethical standards

Conflict of interest

The authors declare that there are no conflicts of interest.

References

  1. Aebi H (1984) Catalase in vitro Methods Enzymol 105:121–126Google Scholar
  2. An LJ, Guan S, Shi GF, Bao YM, Duan YL, Jiang B (2006) Protocatechuic acid from Alpiniaoxyphylla against MPP + −induced neurotoxicity in PC12 cells. Food Chem Toxicol 44:436–443CrossRefPubMedGoogle Scholar
  3. Bettio LEB, Freitas AE, Neis VB, Santos DB, Ribeiro CM, Rosa RB (2014) Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress. Pharmacol Biochem Behav 127:7–14CrossRefPubMedGoogle Scholar
  4. Budni J, Zomkowski AD, Engel D, Santos DB, dos Santos A, Moretti M et al (2013) Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp Neurol 240:112–121CrossRefPubMedGoogle Scholar
  5. Burri A, Maercker A, Krammer S, Simmen-Janevska K (2013) Childhood trauma and PTSD symptoms increase the risk of cognitive impairment in a sample of former indentured child laborers in old age. PLoS One 8:e57826CrossRefPubMedPubMedCentralGoogle Scholar
  6. Buynitsky T, Mostofsky DI (2009) Restraint stress in biobehavioral research: recent developments. Neurosci Biobehav Rev 7:1089–1098CrossRefGoogle Scholar
  7. Calabrese F, Molteni R, Riva, MA, (2011) Antistress properties of antidepressant drugs and their clinical implications Pharmacol Ther 132:39–56Google Scholar
  8. Capra JC, Cunha MP, Machado DG, Zomkowski AD, Mendes BG, Santos AR, Pizzolatti MG, Rodrigues AL (2010) Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur J Pharmacol 643:232–238CrossRefPubMedGoogle Scholar
  9. Christiansen SH, Olesen MV, Wortwein G, Woldbye DP (2011) Fluoxetine reverts chronic restrain stress induced depression like behavior and increase neuropeptide Y and galanin expression in mice. Behav Brain Res 216:585–591CrossRefPubMedGoogle Scholar
  10. Chrousos GP (2009) Stress and disorders of stress system. Nat Rev Endocrinol 5:374–381CrossRefPubMedGoogle Scholar
  11. Crupi R, Mazzon E, Marino A, La Spada G, Bramanti P, Cuzzocrea S, Spina E (2010) Melatonin treatment mimics the antidepressant action in chronic corticosterone-treated mice. J Pineal Res 49:123–129PubMedGoogle Scholar
  12. de Balk RS, Bridi JC, Portella Rde L, Carvalho NR, Dobrachinski F et al (2010) Clomipramine treatment and repeated restraint stress alter parameters of oxidative stress in brain regions of male rats. Neurochem Res 35:1761–1770CrossRefGoogle Scholar
  13. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–72CrossRefPubMedGoogle Scholar
  14. Enache M, Van Waes V, Vinner E, Lhermitte M, Maccari S, Darnaudéry M (2008) Impact of an acute exposure to ethanol on the oxidative stress status in the hippocampus of prenatal restraint stress adolescent male rats. Brain Res 1191:55–62CrossRefPubMedGoogle Scholar
  15. Fontella FU, Siqueira IR, Vasconcellos AP, Tabajara AR, Netto CA, Dalmaz C (2005) Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochem Res 30:105–111CrossRefPubMedGoogle Scholar
  16. Freitas AE, Bettio LEB, Neis VB, Santos DB, Ribeiro CM et al (2014) Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. Prog Neuro-Psychopharmacol Biol Psych 50:143–150CrossRefGoogle Scholar
  17. Gold PW, Goodwin FK, Chrousos GP (1988) Clinical and biochemical manifestations of depression relation to the neurobiology of stress. N Engl J Med 319:413–420CrossRefPubMedGoogle Scholar
  18. Guan S, Bao YM, Jiang B, An LJ (2006) Protective effect of protocatechuic acid from Alpiniaoxyphylla on hydrogen peroxide-induced oxidative PC12 cell death. Eur J Pharmacol 538:73–79CrossRefGoogle Scholar
  19. Hammen C, Kim EY, Eberhart NK (2009) Brennan PA, (2009) chronic and acute stress and the prediction of major depression in women. Depress Anxiety 26:718–723CrossRefPubMedPubMedCentralGoogle Scholar
  20. Jaggi AS, Bhatia N, Kumar N, Anand P, Dhavan R (2011) A review on animal models for screening potential anti-stress agents. Neurol Sci 32:993–1005CrossRefPubMedGoogle Scholar
  21. Jin P, Yu H, Tian-Lan, Zhang F, Quan Z (2015) Antidepressant-like effects of Oleoylethanolamide in a mouse model of chronic unpredictable mild stress. Pharmacol Biochem Behav 133:146–154Google Scholar
  22. Jindal A, Mahesh R, Bhatt S (2013) Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage. Pharmacol Biochem Behav 105:63–70CrossRefPubMedGoogle Scholar
  23. Kalueff AV, Wheaton M, Murphy DL (2007) What’s wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res 179:1–18CrossRefPubMedGoogle Scholar
  24. Kim JH, Kim GH, Hwang KH (2012) Monoamine oxidase and dopamine b-hydroxylase inhibitors from the fruits of Gardenia jasminoides. Biomol Ther 20:214–219CrossRefGoogle Scholar
  25. Kobayashi N, Machida T, Takahashi T, Takatsu H, Shinkai T, Abe K et al (2009) Elevation by oxidative stress and aging of hypothalamic-pituitary-adrenal activity in rats and its prevention by vitamin. Eur J Clin Biochem Nutr 45:207–213CrossRefGoogle Scholar
  26. Kumar A, Goyal R (2008) Quercetin protects against acute immobilization stress-induced behavior and biochemical alterations in mice. J Med Food 11:469–473CrossRefPubMedGoogle Scholar
  27. Kumar A, Garg R, Gaur V, Kumar P (2009) Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress induced behavioral and biochemical alteration in mice. Neurosci Lett 467:72–75CrossRefPubMedGoogle Scholar
  28. Lang UE, Borgwardt S (2013) Molecular mechanism of depression: perspective on new treatment strategies. Cell Physiol Biochem 31:761–777CrossRefPubMedGoogle Scholar
  29. Lee AL, Ogle WO, Sapolsky RM (2002) Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 4:117–128CrossRefPubMedGoogle Scholar
  30. Lee B, Shim I, Lee HJ, Yang Y, Hahm DH (2009) Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci Lett 453:151–156CrossRefPubMedGoogle Scholar
  31. Lin WL, Hsieh YJ, Chou FP, Wang CJ, Cheng MT, Tseng TH (2003) Hibiscus protocatechuic acid inhibits lipopolysaccharide-induced rat hepatic damage. Arch Toxicol 77:42–47CrossRefPubMedGoogle Scholar
  32. Lovell MA, Xie C, Markesbery WR (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurol 51:1562–1566CrossRefGoogle Scholar
  33. Mao QQ, Huang Z, Zhong XM, Xian YF, Ip SP (2014) Piperine reverses the effects of corticosterone on behavior and hippocampal BDNF expression in mice. Neurochem Int 74:36–41CrossRefPubMedGoogle Scholar
  34. Mazure CM (1998) Life stressor as risk factors in depression. Clin Psychol Sci Pract 5:291–295CrossRefGoogle Scholar
  35. McKinnon MC, Yucel K, Nazarov A, MacQueen GM (2009) A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 34:41–54PubMedPubMedCentralGoogle Scholar
  36. Mishra HP, Fridovich I (1972) Role of superoxide anion in auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–3175Google Scholar
  37. Moretti M, Budni J, Dos Santos DB, Antunes A, Daufenbach JF, Manosso LM (2013) Protective effects of ascorbic acid on behavior and oxidative staturs of restrint-stressed mice. J Mol Neurosci 49:68–79CrossRefPubMedGoogle Scholar
  38. Morris MC, Compas BE, Garber J (2012) Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin Psychol Rev 32:301–315CrossRefPubMedPubMedCentralGoogle Scholar
  39. Muley MM, Thakare VN, Patil RR, Kshirsagar AD, Naik SR (2012) Silymarin improves the behavioral, biochemical and histoarchitecture alterations in focal ischemic rats: comparative evaluation with piracetam and protocatachuic acid. Pharmacol Biochem Behav 102:286–293CrossRefPubMedGoogle Scholar
  40. Muley MM, Thakare VN, Patil RR, Bafna PA, Naik SR (2013) Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Life Sci 93:51–57CrossRefPubMedGoogle Scholar
  41. Naik SR, Thakare VN, Patil SR (2011) Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property. Exp Toxicol Pathol 63:419–431CrossRefPubMedGoogle Scholar
  42. Niki E (2012) Do antioxidants impair signaling by reactive oxygen species and lipid oxidation products? FEBS Lett 586:767–770CrossRefGoogle Scholar
  43. Ohkawa H, Nobuko K (1979) Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefPubMedGoogle Scholar
  44. Ostadhadi S, Imran Khan M, Norouzi-Javidan A, Dehpour AR (2016) Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway. Biomed Pharmacother 81:295–304CrossRefPubMedGoogle Scholar
  45. Pacheco-Palencia LA, Mertens-Talcott S, Talcott ST (2008) Chemical composition, antioxidant properties, and thermal stability of phytochemical enriched oil from acai (Euterpeoleracea Mart). J Agric Food Chem 56:4631–4636CrossRefPubMedGoogle Scholar
  46. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336PubMedGoogle Scholar
  47. Rang HP, Dale MM, Ritter JM, Flower RJ (2007) Selective serotonin reuptake inhibitors pharmacology, pp 566 Churchill Livingstone. Publication, ElsevierGoogle Scholar
  48. Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12(S1):2–19CrossRefPubMedGoogle Scholar
  49. Rodrigues ALS, Rocha JB, Mello CF, Souza DO (1996) Effect of perinatal lead exposure on rat behavior in open-field and two-way avoidance tasks. Pharmacol Toxicol 79:150–156CrossRefPubMedGoogle Scholar
  50. Rosa JM, Dafre AL, Rodrigues AL (2013) Antidepressant like responses in the forced swimming test elicited by glutathione and redox modulation. Behav Brain Res 253:165–172CrossRefPubMedGoogle Scholar
  51. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S (2007) Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Humanist Psychol 22:67–73Google Scholar
  52. Shi GF, An LJ, Jiang B, Guan SI, Bao YM (2006) Alpinia protocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo. Neurosci Lett 403:206–210CrossRefPubMedGoogle Scholar
  53. Thakare VN, Patel BM (2015) Potential targets for the development of novel antidepressants: future perspectives. CNS Neurol Disord Drug Targets 14:270–281CrossRefPubMedGoogle Scholar
  54. Thakare VN, Dhakane VD, Patel BM (2016) Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus. Pharmacol Rep 68:1020–1027CrossRefPubMedGoogle Scholar
  55. Zafir A, Banu N (2007) Antioxidant potential of fluoxetine in comparision to Curcuma longa in restrint-stressed rats. Eur J Pharmacol 572:23–31CrossRefPubMedGoogle Scholar
  56. Zafir A, Ara A, Banu N (2009) In vivo antioxidant status: a putative target for antidepressant action. Prog Neuro-Psychopharmacol Biol Psychiatry 33:220–228CrossRefGoogle Scholar
  57. Zhang YJ, Wu L, Zhang QL, Li J, Yin FX, Yuan Y (2011) Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling. J Ethnopharmacol 136:129–136CrossRefPubMedGoogle Scholar
  58. Zhang H, Li G, Szeto S, Chong C, Quan Q et al (2015) Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson's disease. Free Radic Biol Med 84:331–333CrossRefPubMedGoogle Scholar
  59. Zhao Y, Xie W, Dai J, Wang Z, Huang Y (2009) The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice. Brain Res 1261:82–90CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Vishnu N. Thakare
    • 1
    • 2
  • Valmik D. Dhakane
    • 3
  • Bhoomika M. Patel
    • 2
    Email author
  1. 1.Department of PharmacologySinhgad Institute of Pharmaceutical SciencesLonavalaIndia
  2. 2.Department of Pharmacology, Institute of PharmacyNirma UniversityAhmedabadIndia
  3. 3.Research and Development, Astec Life SciencesMumbaiIndia

Personalised recommendations